Can Shingles Go to Your Brain and Cause Complications?

Shingles can reach the brain, and when it does, the complications range from inflammation of the brain’s lining to full-blown encephalitis and even stroke. The varicella-zoster virus (VZV), the same virus behind chickenpox, lies dormant in nerve cells for decades and can reactivate as shingles. In a small but meaningful fraction of cases, the virus travels beyond the skin nerves and into the central nervous system. A nationwide Swedish study identified roughly 2 cases per 100,000 adults per year, with the risk climbing sharply in people over 70.

How Often Shingles Reaches the Central Nervous System

Most people think of shingles as a painful skin rash confined to a strip on one side of the body. That is the typical course, and the vast majority of episodes stay that way. But the virus can spread from the nerve ganglia where it hides into the spinal cord, brain, or the membranes surrounding them. A large Swedish study covering nearly two decades found an overall incidence of about 1.9 cases of VZV-associated central nervous system infection per 100,000 adults per year. In people over 70, that rate more than doubled to roughly 4.2 per 100,000.¹

Among those nearly 1,500 adult cases, the breakdown by type was revealing. Meningitis, inflammation of the membranes surrounding the brain and spinal cord, was the most frequent form at about 45 percent. Encephalitis, where the brain tissue itself becomes inflamed, accounted for roughly 38 percent. The remaining 17 percent were cases of Ramsay Hunt syndrome, a condition involving cranial nerves near the ear. In older adults, encephalitis was the dominant pattern rather than meningitis.¹

What Brain Involvement Actually Looks Like

The symptoms depend on which part of the central nervous system the virus invades. With meningitis, the classic picture is headache, fever, and a stiff neck. When the infection pushes deeper into the brain itself, confusion, altered consciousness, and seizures can follow, signaling encephalitis.² One of the trickier aspects is that shingles-related encephalitis does not always arrive with a dramatic onset. A person might first notice worsening headaches or subtle changes in thinking before the situation escalates.

On imaging, VZV encephalitis tends to produce scattered lesions beneath the cortex that show rapid damage to the insulating sheaths around nerve fibers. Active spots light up on contrast-enhanced MRI, and swelling or bleeding can develop as the infection progresses.³ In rare instances, these brain lesions can look so much like a tumor that patients have undergone surgery before doctors realized the “mass” was actually VZV-driven inflammation. One documented case involved a lesion initially thought to be a low-grade brain tumor. When the tissue was removed and examined, no cancer cells were found. Instead, testing revealed varicella-zoster virus DNA and inflammatory cells characteristic of a viral process.⁴

Shingles and Stroke

One of the more alarming complications is stroke. VZV does not just infect neurons; it can invade the walls of blood vessels inside the brain, a condition called VZV vasculopathy. This triggers a type of vessel inflammation that remodels and narrows the arteries, restricting blood flow and potentially causing a stroke. Researchers have documented that VZV infection of cerebral arteries directly causes this pathological vascular remodeling.⁵

The stroke risk after shingles is higher than many people realize. Population studies have confirmed an elevated risk, though researchers note that vasculopathy alone does not fully explain the unexpectedly high stroke rates in these patients, suggesting additional mechanisms like systemic inflammation also play a role.⁶ VZV vasculopathy can affect both large and small vessels. When larger arteries near the base of the brain are involved, imaging may reveal narrowing in major cerebral arteries along with signs of infarcts at multiple levels, from the cortex to deep brain structures and the brainstem.⁷

Most of the strokes are ischemic, caused by blocked blood flow, but hemorrhagic strokes happen too. VZV vasculopathy can produce small intracranial bleeds when the inflamed vessel walls weaken and rupture.⁸ This means that in someone with a recent or even unrecognized shingles episode, an unexplained stroke should prompt clinicians to consider VZV involvement.

Ramsay Hunt Syndrome and Brainstem Invasion

Ramsay Hunt syndrome happens when VZV reactivates in the nerve ganglion near the ear, typically causing facial paralysis, ear pain, and blisters in or around the ear canal. Most cases stay at that level. But in some patients, the virus spreads backward along the nerve into the brainstem itself, which is an entirely different level of severity.

One well-documented case described a patient whose VZV traveled from the ear-associated ganglion into the brainstem and cerebellum, affecting multiple brain structures and causing facial paralysis, double vision, and severe problems with balance and coordination.⁹ Another case involved a previously healthy 49-year-old man who developed Ramsay Hunt syndrome complicated by damage to multiple cranial nerves and meningitis. Even after receiving appropriate antiviral treatment, he relapsed with brainstem encephalitis.¹⁰ That relapse highlights something doctors worry about: antiviral therapy does not guarantee resolution once the virus has reached the brain, and the infection can flare again even after what looks like initial improvement.

When There Is No Rash at All

Perhaps the most unsettling aspect of VZV brain complications is that they can happen without the rash that everyone associates with shingles. The condition is called zoster sine herpete, and it means the virus reactivates and spreads internally without producing any visible blisters on the skin. VZV reactivation can produce chronic nerve pain without rash, and it can cause the full range of neurological problems listed above, including encephalitis, meningitis, and vasculopathy, all without the telltale skin eruption.²

This creates a diagnostic nightmare. Doctors looking at a patient with headaches, confusion, or stroke symptoms would normally include VZV on their list of suspects only if they see a shingles rash. Without it, the virus gets overlooked. One reported case involved a 34-year-old man with HIV who arrived with temporal headaches and numbness but no rash whatsoever. Testing of his spinal fluid eventually confirmed VZV-induced brain vasculopathy.¹¹ Another case described VZV meningitis in an adult with a healthy immune system, again confirmed only through spinal fluid testing in the absence of any rash.¹²

Researchers have specifically flagged that central VZV infection is easily misdiagnosed because it is uncommon and because clinicians may not think to test for it when the rash is absent.¹³ The practical implication: if you develop unexplained neurological symptoms like severe headaches, confusion, new weakness on one side, or neck stiffness, VZV should be on the radar even without skin involvement, particularly if you are older or have a weakened immune system.

Who Faces the Highest Risk

Age and immune status are the two biggest factors. Older adults carry a higher burden for a straightforward reason: the immune surveillance that keeps VZV in check weakens with age. The Swedish data showed the highest incidence of CNS infections in people over 70.¹ But age is not the whole story.

People with compromised immune systems, whether from HIV, organ transplants, cancer treatment, or autoimmune medications, face a meaningfully worse course if VZV does reach the brain. A comparative study found that encephalitis was significantly more common in immunocompromised patients with VZV CNS infections compared to those with healthy immune systems. The immunocompromised group also had worse outcomes at discharge. Critically, in both groups, the time between the onset of neurological symptoms and the start of antiviral treatment was an independent predictor of how well patients did. Delays in diagnosis and treatment translated directly into poorer recovery.¹⁴

That last point deserves emphasis. It means the diagnostic confusion described in the previous section is not just academically frustrating. Every hour or day that VZV brain involvement goes unrecognized is a missed window for antiviral therapy that could change the outcome.

A Diagnostic Gray Area Worth Knowing About

Diagnosing VZV brain complications usually relies on testing spinal fluid for VZV DNA using PCR. But there is a wrinkle that complicates interpretation. VZV DNA can show up in the spinal fluid during an active skin-only shingles episode without any actual brain disease. In other words, a positive VZV PCR in the spinal fluid does not always mean the brain or its membranes are infected; the virus can sometimes be detected there as a bystander.¹⁵ Additional testing, including antibody levels in the spinal fluid, can help distinguish true CNS infection from incidental viral presence. Some cases also show elevated protein and increased white blood cells in the spinal fluid, which adds weight to a diagnosis of actual brain or meningeal involvement.¹⁶

This matters for patients because it means that even when doctors do think to test for VZV, interpreting the results requires clinical judgment. A positive test paired with clear neurological symptoms and abnormal spinal fluid points strongly toward CNS disease. A positive test in someone whose only problem is a standard shingles rash might just reflect spillover of viral material into the spinal fluid without true brain involvement.

Long-Term Consequences for the Brain

Surviving VZV encephalitis does not always mean a full return to normal. While some patients recover well, others are left with lasting cognitive problems. One detailed neuropsychological assessment of a previously healthy and immunocompetent patient who survived herpes zoster encephalitis found severe impairment across multiple areas of thinking, including memory, attention, and executive function. The deficits persisted long after the acute infection had resolved.¹⁷ This ran counter to earlier, more optimistic reports that suggested neurological outcomes from VZV encephalitis were generally mild.

Beyond the damage caused by acute encephalitis, a growing body of research suggests that VZV may contribute to brain vulnerability in a more subtle and chronic way. The idea is that even subclinical reactivations of the virus, small flare-ups that never produce noticeable shingles, could act as repeated immune stressors that promote low-grade inflammation in the aging brain. This chronic inflammatory load might contribute to conditions like dementia over time.¹⁸

What the Shingles Vaccine Does for Brain Protection

The connection between VZV and long-term brain health adds another dimension to the argument for vaccination. The recombinant shingles vaccine, Shingrix, is primarily designed to prevent shingles episodes and their direct complications. But the evidence for a secondary brain-protective effect is becoming difficult to ignore.

A large study comparing people who received the newer recombinant vaccine against those who got the older live vaccine found that the recombinant vaccine group had a lower risk of developing dementia over the following six years. The difference translated to about 17 percent more time lived without a dementia diagnosis, or roughly 164 additional diagnosis-free days among those who were eventually affected.¹⁸ Whether this reflects direct suppression of viral activity in the nervous system, reduction in systemic inflammation, or some combination remains an open question. But the signal is strong enough that it has prompted researchers to propose that VZV latency itself contributes to the kind of immune wear and tear that makes aging brains vulnerable.

Regarding the direct neurological complications of shingles, long-term follow-up data on the recombinant vaccine shows sustained protection. Vaccine efficacy against non-postherpetic-neuralgia complications, which includes CNS involvement, was above 90 percent in adults aged 50 and older, and that protection held across more than a decade of follow-up.¹⁹ Breakthrough cases and complications were most common in people over 76 who were furthest from their vaccination date, but even in that group, the vaccine provided meaningful protection compared to no vaccination at all.

When an Unexplained Brain Symptom Might Be Shingles

The cases where VZV mimics other conditions on brain imaging deserve attention from anyone trying to understand how these complications play out. MRI findings in VZV vasculopathy can show multiple areas of stroke-like damage across different brain regions, including spots where the gray and white matter meet and deep structures in the brainstem.⁷ This scattering pattern, affecting both large and small vessels at multiple levels, is actually somewhat distinctive once a clinician thinks to look for it. The problem is getting VZV onto the differential in the first place, especially when there is no rash to prompt that thought.

From a practical standpoint, the people most likely to benefit from this knowledge are those caring for older adults or immunocompromised individuals who develop unexplained neurological symptoms. New-onset confusion, severe headaches with neck stiffness, sudden weakness on one side, visual changes, or problems with balance should always prompt medical attention. If a shingles rash is present or recent, telling the medical team about it becomes critical because it changes the diagnostic workup. And if no rash is present but the person is in a high-risk group, asking whether VZV testing should be considered is reasonable. The virus is treatable with antivirals, and early treatment is the single most consistent predictor of better outcomes across both immunocompromised and immunocompetent patients.¹⁴

1
PubMed Central. Incidence and Risk Factors for Varicella-Zoster Virus-Associated Central Nervous System Infections: A Nationwide Swedish Retrospective Case-Control Study
2
PubMed Central. Neurological Disease Produced by Varicella Zoster Virus Reactivation Without Rash
3
IDCases. An unusual case of varicella zoster encephalitis mimicking a glioblastoma on magnetic resonance imaging and magnetic resonance spectroscopy
4
PubMed Central. Focal herpes zoster encephalitis without a rash: diagnostic confusion between astrogliosis and low-grade glioma
5
PubMed Central. The relationship between herpes zoster and stroke
6
PubMed. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study
7
PubMed Central. Varicella Zoster CNS Vascular Complications: A Report of Four Cases and Literature Review
8
PubMed Central. Hemorrhagic Stroke Due to Varicella Zoster Virus Vasculopathy
9
PubMed Central. Brainstem and Cerebellar Involvement in Ramsay Hunt Syndrome
10
PubMed Central. Ramsay Hunt Syndrome With Multiple Cranial Neuropathies, Meningitis, and Subsequent Brainstem Encephalitis: A Case Report
11
PubMed Central. Zoster Sine Herpete Masquerading as Central Nervous System Vasculitis
12
PubMed Central. Zoster sine herpete complicated by central nervous system infection in an immunocompetent adult: A case report
13
PubMed. Varicella Zoster viral encephalitis without herpes: diagnosis by metagenomic next-generation sequencing of cerebrospinal fluid
14
PubMed Central. Varicella-zoster virus-associated central nervous system infection in immunocompromised vs. immunocompetent herpes zoster patients: a comparative study
15
PubMed Central. Acyclovir-induced neurotoxicity with a positive cerebrospinal fluid varicella zoster PCR result creating a management dilemma: a case report
16
Europe PMC. Shingles with secondary asymptomatic CNS involvement!
17
PubMed Central. Dementia Following Herpes Zoster Encephalitis
18
PubMed Central. The recombinant shingles vaccine is associated with lower risk of dementia
19
Open Forum Infectious Diseases. P-112. Characterization of Herpes Zoster Cases and Sustained High Vaccine Efficacy Against Herpes Zoster Complications in Individuals Vaccinated with Recombinant Zoster Vaccine During A Long-Term Follow-Up Study